FDA — authorised 25 July 1983
- Application: ANDA087954
- Marketing authorisation holder: HOSPIRA
- Local brand name: VITAMIN K1
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Phylloquinone in United States
FDA authorised Phylloquinone on 25 July 1983
Marketing authorisations
FDA — authorised 25 July 1983
- Application: ANDA087955
- Marketing authorisation holder: HOSPIRA
- Local brand name: VITAMIN K1
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 25 July 1983
- Application: ANDA087956
- Marketing authorisation holder: HOSPIRA
- Local brand name: VITAMIN K1
- Indication: INJECTABLE — INJECTION
- Status: approved
Other Cardiovascular approved in United States
Frequently asked questions
Is Phylloquinone approved in United States?
Yes. FDA authorised it on 25 July 1983; FDA authorised it on 25 July 1983; FDA authorised it on 25 July 1983.
Who is the marketing authorisation holder for Phylloquinone in United States?
HOSPIRA holds the US marketing authorisation.